Vaxart, Inc., a privately held, clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced positive results demonstrating...
Vaxart, Inc., a privately held, clinical-stage company developing vaccines that are administered by tablet rather than by injection, Sunday announced that The Lancet Infectious Diseases published an article...
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.